These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25183046)

  • 41. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
    Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
    Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells.
    Gong C; Qu S; Liu B; Pan S; Jiao Y; Nie Y; Su F; Liu Q; Song E
    Oncogene; 2015 Jan; 34(1):84-93. PubMed ID: 24292682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation.
    Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S
    Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
    Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
    J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transforming growth factor (TGF)-β-induced microRNA-216a promotes acute pancreatitis via Akt and TGF-β pathway in mice.
    Zhang J; Ning X; Cui W; Bi M; Zhang D; Zhang J
    Dig Dis Sci; 2015 Jan; 60(1):127-35. PubMed ID: 25501921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.
    Song W; Wu S; Wu Q; Zhou L; Yu L; Zhu B; Gong X
    J Cell Biochem; 2019 Aug; 120(8):14095-14106. PubMed ID: 31087707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2.
    Wang Z; Qin C; Zhang J; Han Z; Tao J; Cao Q; Zhou W; Xu Z; Zhao C; Tan R; Gu M
    Tumour Biol; 2017 Feb; 39(2):1010428317691184. PubMed ID: 28231730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of miR-486-5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF-β-activated kinase 1.
    He Y; Liu J; Wang Y; Zhu X; Fan Z; Li C; Yin H; Liu Y
    J Cell Biochem; 2019 Mar; 120(3):2954-2963. PubMed ID: 30537206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.
    Wang L; Wei WQ; Wu ZY; Wang GC
    Mol Biosyst; 2017 Nov; 13(12):2564-2573. PubMed ID: 29019371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192.
    Sun L; Zhang D; Liu F; Xiang X; Ling G; Xiao L; Liu Y; Zhu X; Zhan M; Yang Y; Kondeti VK; Kanwar YS
    J Pathol; 2011 Nov; 225(3):364-77. PubMed ID: 21984124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.
    Chen H; Li L; Wang S; Lei Y; Ge Q; Lv N; Zhou X; Chen C
    Oncotarget; 2014 Dec; 5(23):11873-85. PubMed ID: 25428912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [microRNA-140 suppresses the migration and invasion of colorectal cancer cells through targeting Smad3].
    Zhao W; Zou J; Wang B; Fan P; Mao J; Li J; Liu H; Xiao J; Ma W; Wang M; Li L; Song B
    Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):739-45. PubMed ID: 25567303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
    Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.
    Guan Z; Song B; Liu F; Sun D; Wang K; Qu H
    J Biomed Sci; 2015 Dec; 22():107. PubMed ID: 26627200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
    Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.